ABBOTT LABORATORIES Executive Compensation
Named executive officer pay as disclosed in the company’s abt-20260311.htm proxy statement (SEC Form DEF 14A). Figures are total annual compensation for the most recent fiscal year reported.
$24,198,660
Robert B. Ford , Chief Executive Officer — total compensation
$1,500,000
base salary
Healthcare
industry
| Executive | Title | Base salary | Total compensation |
|---|---|---|---|
| Robert B. Ford | Chairman of the Board and Chief Executive Officer | $1,500,000 | $24,198,660 |
| Philip P. Boudreau | Executive Vice President, Finance and Chief Financial Officer | $974,231 | $9,090,636 |
| Lisa D. Earnhardt | Executive Vice President and Group President, Medical Devices | $924,231 | $8,069,724 |
| Hubert L. Allen | Former Executive Vice President, General Counsel and Secretary | $524,019 | $6,995,583 |
| Christopher J. Scoggins | Executive Vice President, Diabetes Care | $859,502 | $6,601,667 |
Source: ABBOTT LABORATORIES Definitive Proxy Statement (DEF 14A), filed abt-20260311.htm with the U.S. Securities and Exchange Commission. View the filing on SEC.gov. Total compensation reflects the Summary Compensation Table and includes salary, bonus, stock and option awards, non-equity incentive pay, and all other compensation as defined by SEC rules.
Other Healthcare companies
UNITEDHEALTH GROUP INC
Healthcare
$60,938,062
Stephen Hemsley, CEO
ELI LILLY & Co
Healthcare
$36,698,337
David A. Ricks, CEO
JOHNSON & JOHNSON
Healthcare
$32,758,111
J. Duato, CEO
AbbVie Inc.
Healthcare
$32,530,984
Robert A. Michael, CEO
GILEAD SCIENCES, INC.
Healthcare
$28,437,198
Daniel P, CEO
PFIZER INC
Healthcare
$27,585,301
A. Bourla, CEO
